Revvity RVTY Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Revvity in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Revvity's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Revvity's cash & equivalents?
- Revvity (RVTY) reported cash & equivalents of $861.47M in Q1 2026.
- How has Revvity's cash & equivalents changed year-over-year?
- Revvity's cash & equivalents decreased by 24.3% year-over-year, from $1.14B to $861.47M.
- What is the long-term trend for Revvity's cash & equivalents?
- Over 5 years (2020 to 2025), Revvity's cash & equivalents has grown at a 18.0% compound annual growth rate (CAGR), from $402.61M to $921.03M.
- What does cash & equivalents mean?
- The total amount of cash and highly liquid short-term investments held by the company.
- How do you interpret cash & equivalents?
- An increase suggests improved liquidity or preparation for acquisitions, while a decrease may indicate capital deployment or cash burn.
- How does cash & equivalents compare across companies?
- Standard across all industries; peers in life sciences typically maintain cash buffers to support R&D and M&A activity.